Henry Maia Peixoto

Keywords Vivax malaria G6PD screening Cost-effectiveness analysis Tafenoquine Evidence before this study Using the search terms (“g6pd” OR “Glucose-6-phosphate dehydrogenase”) AND “tafenoquine” AND (“cost-effectiveness” OR “cost”) AND “vivax”, we searched PubMed for studies reporting the cost-effectiveness of prescribing tafenoquine to those with >70% G6PD activity with quantitative screening. Only one study was identified.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Keywords Heart failure Dapagliflozin Cost-effectiveness QALY Brazil Evidence before this study Sodium-glucose cotransporter-2 (SGLT2) inhibitors, originally developed for the treatment of type 2 diabetes, have been demonstrated to enhance cardiovascular outcomes in several clinical trials.